CURIS, INC. Increase (Decrease) in Interest Payable, Net
CURIS, INC. (CRIS) reported Increase (Decrease) in Interest Payable, Net of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2017-03-09
- CURIS, INC. increase (decrease) in interest payable, net for fiscal 2016 was $0.00.
- CURIS, INC. increase (decrease) in interest payable, net for fiscal 2015 was $0.00.
- CURIS, INC. increase (decrease) in interest payable, net for fiscal 2014 was -$714.00K, a 200.00% decline from fiscal 2013.
- CURIS, INC. increase (decrease) in interest payable, net for fiscal 2013 was $713.97K.
| Period end | Increase (Decrease) in Interest Payable, Net 12 month | Increase (Decrease) in Interest Payable, Net 12 month as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-09 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-09 | |
| 2014-12-31 | -$714.00K 10-K · filed 2017-03-09 | -$713.97K 10-K · filed 2016-02-29 |
| 2013-12-31 | $713.97K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |